Results 211 to 220 of about 1,389,605 (343)

Discontinuous synthesis of lac messenger ribonucleic acid in a mutant of Escherichia coli with a new lac promoter [PDF]

, 1976
Jeremy A. Bruenn, William H. Kane
openalex   +1 more source

Extensive Promoter-Centered Chromatin Interactions Provide a Topological Basis for Transcription Regulation

Cell, 2012
Guoliang Li, Xiaoan Ruan, Raymond K. Auerbach, K. Sandhu, Meizhen Zheng, Ping Wang, H. Poh, Yufen Goh, Joanne Lim, Jingyao Zhang, Hui Shan Sim, Su Qin Peh, F. Mulawadi, C. T. Ong, Y. Orlov, Shuzhen Hong, Zhizhuo Zhang, S. Landt, D. Raha, G. Euskirchen, Chia-Lin Wei, W. Ge, Huaien Wang, Carrie A. Davis, Katherine I. Fisher-Aylor, A. Mortazavi, M. Gerstein, T. Gingeras, B. Wold, Y. Sun, M. Fullwood, E. Cheung, E. Liu, W. Sung, M. Snyder, Y. Ruan   +35 more
semanticscholar   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

Nucleotide Sequence in the Promoter Region of the Escherichia coli Tyrosine tRNA Gene

, 1974
Takao Sekiya, H. Gobind Khorana
openalex   +1 more source

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

Molecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed, Lucas Mani, Muhammad Bilal Mirza, Ashtyn McAdoo, Takahito Kondo, Hidenori Tanaka, Nicole Meeks, Eben Rosenthal, Marisa Hom   +8 more
wiley   +1 more source

Transcription Dynamics and DNA Methylation Responses to Growth Modification. [PDF]

Mar Biotechnol (NY)
Christensen KA, Collette É, Perley D, Sakhrani D, Muttray AF, Leggatt RA, Biagi CA, Koop BF, Devlin RH.   +8 more
europepmc   +1 more source

Saccharin: from carcinogen to promoter [PDF]

, 1979
E. Boyland
openalex   +1 more source

The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer

Science, 2015
Robert J. A. Bell, H. T. Rube, Alex Kreig, A. Mancini, S. Fouse, R. Nagarajan, Serah Choi, C. Hong, Daniel He, M. Pekmezci, J. Wiencke, M. Wrensch, Susan M. Chang, K. Walsh, Sua Myong, Jun S. Song, J. Costello   +16 more
semanticscholar   +1 more source

Loss of primary cilia promotes EphA2‐mediated endothelial‐to‐mesenchymal transition in the ovarian tumor microenvironment

Molecular Oncology, EarlyView.
Loss of primary cilia in endothelial cells promotes EndMT and vascular abnormalities in the ovarian tumor microenvironment through EphA2 activation. Using human samples, in vitro models, and endothelial‐specific Kif3a‐knockout mice, we show that primary cilia loss drives the acquisition of cancer‐associated fibroblast‐like phenotypes, thereby ...
Jin Gu Cho, Yubin Hah, Eunsik Yun, Hye In Ka, Aram Lee, Sora Han, Dawn Lee, Sung Wook Kim, Jong Hoon Park, Byung Su Kwon, Young Yang, Jongmin Kim   +11 more
wiley   +1 more source

Generation of Odorant Receptor-QF2 Knock-In Drivers for Improved Analysis of Olfactory Circuits in Drosophila. [PDF]

Genes Cells
Ukita Y, Suzuki R, Miyoshi K, Saito K, Okumura M, Chihara T.   +5 more
europepmc   +1 more source